Doss, Manoj K. http://orcid.org/0000-0003-2939-2522
Považan, Michal
Rosenberg, Monica D. http://orcid.org/0000-0001-6179-4025
Sepeda, Nathan D.
Davis, Alan K.
Finan, Patrick H.
Smith, Gwenn S. http://orcid.org/0000-0003-0706-5440
Pekar, James J.
Barker, Peter B. http://orcid.org/0000-0002-6410-7793
Griffiths, Roland R. http://orcid.org/0000-0001-5185-7854
Barrett, Frederick S.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (T32DA007209, R01DA03889)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Heffter Research Institute, Steven and Alexandra Cohen Foundation, Tim Ferriss, Blake Mycoskie, Matt Mullenweg, Craig Nerenberg, the Riverstyx Foundation, and Dave Morin.
Article History
Received: 7 June 2021
Revised: 14 October 2021
Accepted: 26 October 2021
First Online: 8 November 2021
Competing interests
: MKD is on the scientific advisory board for Ocean Bio Limited. AKD is a board member of Source Research Foundation. PHF is on the scientific advisory board for and has an equity position in Ninnion Therapeutics. RRG is a board member of the Heffter Research Institute. FSB is an advisor to Wavepaths. All other authors have no competing interests to declare.